MedTrace Logo

Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections

NCT06050148 · Status: RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-09-22

No results posted yet for this study

Summary

This study investigates Faecal microbiota transplantation (FMT) in prevention of recurrent urinary tract infections (UTIs) caused either by sensitive E. coli or ESBL-E. coli.

Conditions

  • Recurrent Urinary Tract Infection

Interventions

BIOLOGICAL

Feacal microbial transplantation (FMT)

Feacal microbial transplantation (FMT)

OTHER

Placebo transplantation (PT)

Transplantation with coloured 0,9% NaCl-solution

Sponsors & Collaborators

  • University of Helsinki

    collaborator OTHER

  • Helsinki University Central Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2028-12-31
Completion
2029-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06050148 on ClinicalTrials.gov